Study to examine methods to reduce damage of radiotherapy to normal tissue

October 1, 2012
A new research programme at the University of Cambridge hopes to improve cancer cure rates by reducing toxicity from radiotherapy.

About half of all people with cancer receive a course of radiotherapy, a form of treatment in which X-rays are used to shrink or destroy the tumour. With the benefit of advanced systems, it is now possible to aim radiation beams at tumours more effectively than ever before, allowing increasing doses of radiotherapy with increased cancer cure rates, and also reducing side effects.

However, although clinicians use planning software to define the target area for treatment and deliver the , any dose that falls outside the target area – for instance due to the positioning of the patient and their internal organs during treatment – can cause permanent and severe damage to normal tissues.

Now, a new research programme at the University of Cambridge aims to reduce levels of toxicity from , enabling doses of the treatment to be escalated. By examining to what extent the dose of radiation planned by the clinician for a patient differs from that which the patient actually receives – and how this damages normal, healthy tissues – the programme will develop a set of tools that can be used to provide patients with the for their condition.

"We are breaking new ground thanks to the marshalling of forces from several fields," said Professor Neil Burnet, who leads the research. Expertise is being pooled from a cross-disciplinary group of clinicians and scientists from the University of Cambridge Departments of Oncology, Physics, Engineering, and Applied Mathematics and , the NHS Oncology Centre, and the Cancer Research UK (CRUK) Cambridge Research Institute.

"The aim will always be to safely deliver radiation to the tumour and so kill the ," he added. "Although modern technology has improved side effects, 29% of patients are still left with significant dry mouth after head and neck radiotherapy because of damage to the salivary glands, and 10% of men experience severe toxicity after prostate radiotherapy because of rectal damage. Hormonal dysfunction after radiotherapy damage to the hypothalamus and pituitary gland can result in a patient needing lifelong hormone replacement therapy."

The VoxTox Research Programme, a five-year study funded by CRUK, focuses on reducing radiation toxicity. After quantifying the differences between planned dose and the dose actually delivered during the whole course of radiotherapy, the programme will link these data to differences between expected and observed toxicity. It will look into the physical factors behind dose variation such as movement of , as well as suspected biological factors, such as a patient's genetic make-up.

"In Cambridge there is a unique archive of daily computed tomography (CT) scans – imaging data acquired during the course of a patient's high-precision image-guided radiotherapy on our TomoTherapy treatment machines," said Burnet. "Systems will be developed to map the location of each point, or voxel, within the patient outline, and then to re-compute the dose at that point each day during treatment."

The study will develop a suite of integrated software tools for dose review during the treatment course, with the objective of individualising based on predicted toxicity, and make these tools available to the world cancer community.

Explore further: Project to improve radiotherapy planning

Related Stories

Project to improve radiotherapy planning

January 30, 2012
A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. Accel-RT ...

Radiotherapy doses to be more accurate

April 13, 2012
Cancer patients undergoing radiotherapy treatments in future will be safer thanks to a collaborative piece of research by NPL, the University of Montreal, and McGill University which will result in improved measurement consistency.

A promising step forward in prostate cancer treatment

August 6, 2012
When treating prostate cancer with radiotherapy, knowing the prostate cancer position is critical to accurately targeting the radiation beam to avoid missing the tumour and irradiating healthy tissue. Prostate cancer patients ...

IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients

September 26, 2011
Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved ...

Jefferson doctors strengthen case for high-dose radiotherapy technique after radical prostatectomy

April 13, 2011
A widely-available yet expensive radiotherapy technique used to treat prostate cancer patients after surgery has promising benefits -- higher dose and less damage to the rectum and bladder -- compared to a less precise technique, ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

New study reveals breast cancer cells recycle their own ammonia waste as fuel

October 19, 2017
Breast cancer cells recycle ammonia, a waste byproduct of cell metabolism, and use it as a source of nitrogen to fuel tumor growth, report scientists from Harvard Medical School in the journal Science.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.